Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GRO

Agria Co. American Depo (GRO) Stock Price, News & Analysis

About Agria Co. American Depo Stock (NYSE:GRO)

Advanced Chart

Key Stats

Today's Range
$1.47
$1.55
50-Day Range
N/A
52-Week Range
$0.71
$1.66
Volume
95,681 shs
Average Volume
36,354 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Strong Buy

Company Overview

Receive GRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agria Co. American Depo and its competitors with MarketBeat's FREE daily newsletter.

GRO Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

GRO Stock Analysis - Frequently Asked Questions

Agria Co. American Depo (GRO) raised $71 million in an initial public offering (IPO) on Tuesday, November 26th 2024. The company issued 4,300,000 shares at $15.00-$18.00 per share. Cantor, Bradesco BBI, Freedom Capital Markets and Roth Capital Partners served as the underwriters for the IPO and Clarksons Securities was co-manager.

Agria Co. American Depo's lock-up period expired on Monday, May 26th. Agria Co. American Depo had issued 2,000,000 shares in its public offering on November 27th. The total size of the offering was $30,000,000 based on an initial share price of $15.00. Since the expiration of Agria Co. American Depo's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agria Co. American Depo investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Amarin (AMRN), Ampliphi Biosciences (APHB) and ArQule (ARQL).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:GRO
CIK
1413257
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$5.50
Low Price Target
$5.50
Potential Upside/Downside
+264.2%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:GRO) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners